U.S. patent number D492,995 [Application Number D/179,382] was granted by the patent office on 2004-07-13 for implanting device.
This patent grant is currently assigned to Valera Pharmaceuticals, Inc.. Invention is credited to Matthew L. Rue, David S. Teirney.
United States Patent |
D492,995 |
Rue , et al. |
July 13, 2004 |
Implanting device
Claims
We claim the ornamental design for an implanting device, as shown
and described.
Inventors: |
Rue; Matthew L. (Flemington,
NJ), Teirney; David S. (Cranberry, NJ) |
Assignee: |
Valera Pharmaceuticals, Inc.
(Cranbury, NJ)
|
Appl.
No.: |
D/179,382 |
Filed: |
April 9, 2003 |
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
|
406397 |
Apr 3, 2003 |
|
|
|
|
Current U.S.
Class: |
D24/133; D24/113;
D24/146 |
Current International
Class: |
2402 |
Field of
Search: |
;D24/133,113,146,147
;604/57,60,59 ;600/7,8 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Simmons; Ian
Attorney, Agent or Firm: Miller; Raymond A. Pepper Hamilton
LLP
Description
FIG. 1 is a perspective view of the implanting device showing our
new design, the portion of the drawings illustrated by broken lines
forming no part of the design sought to be patented;
FIG. 2 is a bottom view thereof, the portion of the drawing
illustrated by broken lines forming no part of the design sought to
be patented;
FIG. 3 is a right side view thereof with the left side being a
mirror image, the portion of the drawing illustrated by broken
lines forming no part of the design sought to be patented.
FIG. 4 is a top view thereof, the portion of the drawing
illustrated by broken lines forming no part of the design sought to
be patented;
FIG. 5 is a front view thereof, the portion of the drawing
illustrated by broken lines forming no part of the design sought to
be patented;
FIG. 6 is a rear view thereof; and,
FIG. 7 is another perspective view thereof, the portion of the
drawings illustrated by broken lines forming no part of the design
sought to be patented.
* * * * *